Literature DB >> 19524065

HIF-1 attenuates Ref-1 expression in endothelial cells: reversal by siRNA and inhibition of geranylgeranylation.

Agnieszka Loboda1, Anna Stachurska, Jerzy Dorosz, Marek Zurawski, Joanna Wegrzyn, Magdalena Kozakowska, Alicja Jozkowicz, Jozef Dulak.   

Abstract

Redox factor-1 (Ref-1), a multifunctional protein with DNA repairing activities, plays a cytoprotective function by post-translational redox modification of numerous transcription factors, including hypoxia inducible factor-1 (HIF-1). In the present study, activation of HIF-1 by hypoxia and dimethyloxaloylglycine (DMOG), a hypoxia mimic, diminished Ref-1 mRNA and protein expression in human microvascular endothelial cells (HMEC-1). Similarly, adenoviral delivery of the stabilized form of HIF-1alpha decreased Ref-1 mRNA and protein levels. Accordingly, HIF-1alpha siRNA abolished the hypoxia-induced inhibition of Ref-1 expression, indicating the role of HIF-1 in down-regulation of Ref-1. Also, translocation of Ref-1 from nucleus to cytoplasm after HIF-1 activation was noted. Interestingly, we observed the restoration of Ref-1 expression in hypoxia by pharmacologically relevant doses of atorvastatin. This effect was dependent on the inhibition of protein geranylgeranylation, but not farnesylation, as only the inhibitor of the former but not the latter prenylation step restored the Ref-1 expression. The regulation of Ref-1 by statins may be considered as a novel mechanism of their beneficial effects on endothelium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524065     DOI: 10.1016/j.vph.2009.05.005

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  8 in total

Review 1.  APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.

Authors:  Mark R Kelley; Millie M Georgiadis; Melissa L Fishel
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

2.  Pharmacological stimulation of hypoxia inducible factor-1α facilitates the corticosterone response to a mild acute stressor.

Authors:  Constance S Harrell; Sydney A Rowson; Gretchen N Neigh
Journal:  Neurosci Lett       Date:  2015-05-29       Impact factor: 3.046

Review 3.  Redox regulation of DNA repair: implications for human health and cancer therapeutic development.

Authors:  Meihua Luo; Hongzhen He; Mark R Kelley; Millie M Georgiadis
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

4.  Aristolochic acid I and ochratoxin A differentially regulate VEGF expression in porcine kidney epithelial cells--the involvement of SP-1 and HIFs transcription factors.

Authors:  Anna Stachurska; Magdalena Kozakowska; Alicja Jozkowicz; Jozef Dulak; Agnieszka Loboda
Journal:  Toxicol Lett       Date:  2011-04-29       Impact factor: 4.372

Review 5.  Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair.

Authors:  Yuliya Mikhed; Agnes Görlach; Ulla G Knaus; Andreas Daiber
Journal:  Redox Biol       Date:  2015-06-03       Impact factor: 11.799

6.  Changes in the Plasma Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1(APE1/Ref-1) Level during Cancer Surgery: An Observational Study.

Authors:  Yumin Jo; Yeojung Kim; Eunhye Park; Yuran Lee; Jiyeon Kim; Minwoong Kang; Jaesung Lim; Insang Song; Chaeseong Lim; Byeonghwa Jeon
Journal:  Medicina (Kaunas)       Date:  2021-11-21       Impact factor: 2.430

Review 7.  miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target.

Authors:  Marcin Serocki; Sylwia Bartoszewska; Anna Janaszak-Jasiecka; Renata J Ochocka; James F Collawn; Rafał Bartoszewski
Journal:  Angiogenesis       Date:  2018-01-27       Impact factor: 9.596

8.  The regulatory role of APE1 in epithelial-to-mesenchymal transition and in determining EGFR-TKI responsiveness in non-small-cell lung cancer.

Authors:  Xiao Yang; Yu Peng; Xuan Jiang; Xianfeng Lu; Wei Duan; Shiheng Zhang; Nan Dai; Jinlu Shan; Yan Feng; Xuemei Li; Yi Cheng; Yuxin Yang; Laura Baugh; Gianluca Tell; Dong Wang; Mengxia Li
Journal:  Cancer Med       Date:  2018-08-14       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.